Published in Kidney Int on October 01, 2003
C1q nephropathy: features at presentation and outcome. Pediatr Nephrol (2005) 2.29
C1q nephropathy in association with Gitelman syndrome: a case report. Pediatr Nephrol (2006) 1.75
A single-center study of C1q nephropathy in children. Pediatr Nephrol (2008) 1.50
C1q nephropathy with asymptomatic urine abnormalities. Pediatr Nephrol (2005) 1.49
Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol (2008) 1.19
Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol (2009) 1.16
Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report. Am J Kidney Dis (2010) 1.04
C1Q nephropathy in children. Pediatr Nephrol (2005) 1.03
Current status and issues of C1q nephropathy. Clin Exp Nephrol (2009) 0.94
Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients. Adv Chronic Kidney Dis (2011) 0.94
Concurrent diabetic nephropathy and C1q nephropathy in a young male patient: The first report in literature. J Nephropathol (2013) 0.94
Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol (2008) 0.93
Diverse clinical and histology presentation in c1q nephropathy. Nephrourol Mon (2013) 0.86
Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy. Clin Exp Nephrol (2010) 0.86
Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome? Pediatr Nephrol (2013) 0.82
Proteinuria in a boy with infectious mononucleosis, C1q nephropathy, and Dent's disease. J Korean Med Sci (2007) 0.82
Pathology of Podocytopathies Causing Nephrotic Syndrome in Children. Front Pediatr (2016) 0.81
C1q nephropathy in children: clinical characteristics and outcome. Pediatr Nephrol (2013) 0.81
Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution. Pediatr Nephrol (2008) 0.80
C1q nephropathy and minimal change nephrotic syndrome. Pediatr Nephrol (2008) 0.79
C1q nephropathy in a child with a chromosome 13 deletion. Pediatr Nephrol (2006) 0.78
C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon? NDT Plus (2009) 0.75
C1q Nephropathy: The Unique Underrecognized Pathological Entity. Anal Cell Pathol (Amst) (2015) 0.75
C1q nephropathy- unity in diversity. J Renal Inj Prev (2013) 0.75
Non-nephronal hematuria misdiagnosed as C1q nephropathy: Look before you leap. Indian J Nephrol (2012) 0.75
Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis. J Nephropathol (2015) 0.75
C1q nephropathy in a patient with Gitelman syndrome. NDT Plus (2011) 0.75
Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis. Clin Exp Nephrol (2012) 0.75
C1q nephropathy in two young sisters. Pediatr Nephrol (2007) 0.75
C1q nephropathy in a child presenting with recurrent gross hematuria. Pediatr Nephrol (2010) 0.75
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77
Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis (2004) 4.20
Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int (2010) 2.95
C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85
Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol (2012) 2.83
Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2008) 2.57
Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol (2004) 2.53
Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Kidney Int (2003) 2.47
Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol (2009) 2.45
Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int (2011) 2.43
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol (2003) 2.43
Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int (2004) 2.39
ANCA-associated glomerulonephritis in the very elderly. Kidney Int (2010) 2.36
Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol (2005) 2.36
Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology (2008) 2.16
Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med (2002) 2.10
Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol (2008) 2.08
IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum Pathol (2003) 2.04
Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int (2004) 2.01
Role of the retinoic acid receptor-α in HIV-associated nephropathy. Kidney Int (2010) 1.89
Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant (2005) 1.89
Bacterial infection-related glomerulonephritis in adults. Kidney Int (2013) 1.87
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest (2002) 1.81
The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int (2013) 1.79
Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol (2009) 1.79
Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice. Diabetes (2013) 1.74
Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol (2008) 1.72
Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest (2004) 1.71
Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol (2009) 1.70
The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury. Kidney Int (2013) 1.70
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol (2011) 1.67
Mycophenolate mofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol (2006) 1.64
Myeloproliferative neoplasms cause glomerulopathy. Kidney Int (2011) 1.62
Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2011) 1.60
Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2010) 1.60
Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol (2011) 1.58
Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore) (2008) 1.57
Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol (2010) 1.57
Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. J Clin Invest (2009) 1.49
De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases. Nephrol Dial Transplant (2005) 1.48
Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol (2008) 1.46
Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol (2010) 1.45
Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int (2003) 1.45
Pathology after eculizumab in dense deposit disease and C3 GN. J Am Soc Nephrol (2012) 1.43
IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract (2011) 1.41
Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol (2002) 1.39
Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A (2004) 1.38
HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS (2005) 1.36
Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury. Kidney Int (2009) 1.34
Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest (2010) 1.34
Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways. Am J Physiol Renal Physiol (2007) 1.34
The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int (2008) 1.33
Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol (2006) 1.30
Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol (2007) 1.30
Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol (2011) 1.29
The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol (2013) 1.26
Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Lab Invest (2010) 1.23
Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab Invest (2008) 1.22
Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am J Physiol Renal Physiol (2007) 1.20
Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies. Am J Kidney Dis (2012) 1.19
Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol (2013) 1.19
A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol (2010) 1.18
NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J Am Soc Nephrol (2005) 1.18
Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J Am Soc Nephrol (2006) 1.17
Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol (2007) 1.15
Renal biopsy in the very elderly. Clin J Am Soc Nephrol (2009) 1.15
A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure. Am J Physiol Renal Physiol (2002) 1.13
Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol (2012) 1.13
Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury. Hepatology (2011) 1.12
Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med (2011) 1.12
A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci U S A (2005) 1.11
Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol (2009) 1.08
Mice that overexpress human heat shock protein 27 have increased renal injury following ischemia reperfusion. Kidney Int (2008) 1.08
Ichthyotoxic ARF after fish gallbladder ingestion: a large case series from Vietnam. Am J Kidney Dis (2003) 1.07
Classification of lupus nephritis. Curr Opin Nephrol Hypertens (2009) 1.07
Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. Lab Invest (2010) 1.06
Renalase protects against ischemic AKI. J Am Soc Nephrol (2013) 1.05
HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. Kidney Int (2008) 1.05
Renal sarcoidosis presenting as acute kidney injury with granulomatous interstitial nephritis and vasculitis. Am J Kidney Dis (2011) 1.04
Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus. Kidney Int (2008) 1.04
Targeted inhibition of complement activation prevents features of preeclampsia in mice. Kidney Int (2010) 1.04
Glomerular disease related to anti-VEGF therapy. Kidney Int (2008) 1.03
Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-beta1 pathway. Am J Physiol Renal Physiol (2008) 1.03